Pilot Evaluation of a Management Toolkit for Airway Clearance Therapy in Bronchiectasis (IMPACT BE)

BACKGROUND: Airway clearance therapies (ACTs) are recommended as an integral part of the management of non–cystic fibrosis bronchiectasis (BE) to prevent inflammation, mucus accumulation, and infection that occur because of ineffective secretion clearance. Adherence to ACTs is low, in part because o...

Descripción completa

Detalles Bibliográficos
Autores principales: Solomon, George M., Barker, Alan F., McSpiritt, Elizabeth, Marikovics, Sonja, Quittner, Alexandra L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2023
Materias:
Innovations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117526/
https://www.ncbi.nlm.nih.gov/pubmed/37089683
http://dx.doi.org/10.34197/ats-scholar.2022-0061IN

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117526/
https://www.ncbi.nlm.nih.gov/pubmed/37089683
http://dx.doi.org/10.34197/ats-scholar.2022-0061IN

Ejemplares similares